Patrick Berteloot

3.3k total citations
88 papers, 2.0k citations indexed

About

Patrick Berteloot is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Patrick Berteloot has authored 88 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Reproductive Medicine, 30 papers in Obstetrics and Gynecology and 29 papers in Oncology. Recurrent topics in Patrick Berteloot's work include Ovarian cancer diagnosis and treatment (30 papers), Endometrial and Cervical Cancer Treatments (25 papers) and Breast Cancer Treatment Studies (20 papers). Patrick Berteloot is often cited by papers focused on Ovarian cancer diagnosis and treatment (30 papers), Endometrial and Cervical Cancer Treatments (25 papers) and Breast Cancer Treatment Studies (20 papers). Patrick Berteloot collaborates with scholars based in Belgium, Switzerland and United States. Patrick Berteloot's co-authors include Ignace Vergote, Frédéric Amant, Patrick Neven, Karin Leunen, Philippe Moerman, Robert Paridaens, Patrick Neven, Erik Van Limbergen, Hans Wildiers and Toon Van Gorp and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Patrick Berteloot

86 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Berteloot Belgium	25	821	741	723	458	360	88	2.0k
Kristina Lindemann Norway	25	900 1.1×	748 1.0×	985 1.4×	227 0.5×	327 0.9×	111	2.1k
Florian Heitz Germany	33	1.9k 2.3×	1.1k 1.5×	894 1.2×	1.0k 2.2×	431 1.2×	180	3.2k
Jacobus Pfisterer Germany	17	1.9k 2.3×	651 0.9×	760 1.1×	932 2.0×	273 0.8×	34	2.5k
Soon‐Beom Kang South Korea	24	616 0.8×	312 0.4×	821 1.1×	288 0.6×	162 0.5×	62	1.5k
W. Qian United Kingdom	18	861 1.0×	703 0.9×	297 0.4×	532 1.2×	143 0.4×	39	1.8k
Victoria M. Chia United States	19	331 0.4×	667 0.9×	224 0.3×	415 0.9×	212 0.6×	36	1.6k
Pınar Saip Türkiye	21	316 0.4×	606 0.8×	169 0.2×	337 0.7×	354 1.0×	115	1.6k
Nicholas Reed United Kingdom	19	655 0.8×	426 0.6×	839 1.2×	401 0.9×	74 0.2×	45	1.6k
David M. Boruta United States	28	1.6k 1.9×	419 0.6×	1.9k 2.6×	727 1.6×	166 0.5×	77	2.7k
James J. Burke United States	17	674 0.8×	242 0.3×	984 1.4×	267 0.6×	133 0.4×	27	1.6k

Countries citing papers authored by Patrick Berteloot

Since Specialization

Citations

This map shows the geographic impact of Patrick Berteloot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Berteloot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Berteloot more than expected).

Fields of papers citing papers by Patrick Berteloot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Berteloot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Berteloot. The network helps show where Patrick Berteloot may publish in the future.

Co-authorship network of co-authors of Patrick Berteloot

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Berteloot. A scholar is included among the top collaborators of Patrick Berteloot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Berteloot. Patrick Berteloot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baelen, Karen Van, Hans Wildiers, Giuseppe Floris, et al.. (2024). Abstract PO3-05-05: The effect of histological breast cancer subtype on progression free survival in patients with CDK4/6 inhibitors. Cancer Research. 84(9_Supplement). PO3–5.

Vandecaveye, Vincent, Raphaëla C. Dresen, Els Van Nieuwenhuysen, et al.. (2022). 2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer. International Journal of Gynecological Cancer. 32. A273–A274. 1 indexed citations

Punie, Kevin, Hans Wildiers, Benoit Beuselinck, et al.. (2018). Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer. Breast Cancer Research and Treatment. 171(1). 131–141. 10 indexed citations

Cann, Thomas Van, Patrick Schöffski, Paul Clement, et al.. (2017). Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab. Acta Clinica Belgica. 73(2). 100–109. 40 indexed citations

Michielsen, Katrijn, Raphaëla C. Dresen, Ragna Vanslembrouck, et al.. (2017). Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. European Journal of Cancer. 83. 88–98. 89 indexed citations

Brouckaert, Olivier, Annouschka Laenen, Joke Vanderhaegen, et al.. (2012). Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers. Annals of Oncology. 23(10). 2578–2584. 45 indexed citations

Cadron, Isabelle, et al.. (2012). Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer. European Journal of Cancer. 48(9). 1332–1340. 21 indexed citations

Vandenput, Ingrid, Jone Trovik, Ignace Vergote, et al.. (2011). The Role of Adjuvant Chemotherapy in Surgical Stages I–II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium: A Collaborative Study. International Journal of Gynecological Cancer. 21(2). 332–336. 17 indexed citations

Neven, Patrick, Ben Van Calster, Sabine Van Huffel, et al.. (2007). Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer. Breast Cancer Research and Treatment. 110(1). 153–159. 12 indexed citations

10.

Vergote, Ignace, Frédéric Amant, Karin Leunen, et al.. (2006). Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrant. International Journal of Gynecological Cancer. 16(s2). 524–526. 11 indexed citations

11.

Mieghem, Tim Van, Karin Leunen, Nathalie Pochet, et al.. (2006). The influence of body composition and hormone replacement therapy (HRT) on progesterone receptor (PR) expression in postmenopausal women with an oestrogen receptor (ER)-positive breast cancer. International Journal of Gynecological Cancer. 16(2). 589–598. 3 indexed citations

12.

Neven, Patrick, M. Drijkoningen, Nathalie Pochet, et al.. (2006). The estrogen receptor has a prognostic value in progesterone receptor-positive breast cancer. 3 indexed citations

13.

Amant, Frédéric, et al.. (2006). Transition of endometrial stromal sarcoma into high-grade sarcoma. Gynecologic Oncology. 103(3). 1137–1140. 33 indexed citations

14.

Morales, Leilani, Steven Pans, Robert Paridaens, et al.. (2006). Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Research and Treatment. 104(1). 87–91. 95 indexed citations

15.

Huang, Huei‐Jean, M. Drijkoningen, Robert Paridaens, et al.. (2005). Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer. Journal of Clinical Pathology. 58(6). 611–616. 139 indexed citations

16.

Vergote, Ignace, Toon Van Gorp, Frédéric Amant, Patrick Neven, & Patrick Berteloot. (2005). Neoadjuvant chemotherapy for ovarian cancer.. PubMed. 19(12). 1615–22; discussion 1623. 30 indexed citations

17.

Vergote, Ignace, Frédéric Amant, Patrick Neven, & Patrick Berteloot. (2004). Endocrine therapy for metastatic endometrial cancer. European Journal of Cancer Supplements. 2(9). 67–69. 1 indexed citations

18.

Amant, Frédéric, Philippe Moerman, Isabelle Cadron, et al.. (2003). The diagnostic problem of endometrial stromal sarcoma: report on six cases. Gynecologic Oncology. 90(1). 37–43. 47 indexed citations

19.

Amant, Frédéric, Philippe Moerman, Isabelle Cadron, et al.. (2002). The diagnostic problem of endometrial stromal sarcoma. International Journal of Gynecological Cancer. 12(5). 2 indexed citations

20.

Vergote, Ignace, et al.. (2002). Laparoscopic assisted vaginal hysterectomy (LAVH) in Stage I endometrial cancer does not increase the incidence of positive peritoneal cytology. Gynecologic Oncology. 84(3). 535–536. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact